Rossari Biotech Complete Financial Statements
ROSSARI • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019
Complete Financial Data Export
Export complete financial statements for Rossari Biotech (ROSSARI).
Downloads include all available records across all periods.
For market performance, see the
ROSSARI stock price today
.
Profitability Ratios
Net Profit Margin
6.29%
2025 data
EBITDA Margin
12.59%
2025 data
Operating Margin
12.00%
2025 data
Return on Assets
1.95%
2025 data
Return on Equity
3.12%
2025 data
Balance Sheet Ratios
Current Ratio
5.99
2025 data
Debt to Equity
1.60
2025 data
Equity Ratio
62.50%
2025 data
Asset Turnover
0.31
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+17.8%
Year-over-Year
Net Profit Growth
+5.7%
Year-over-Year
EBITDA Growth
+10.4%
Year-over-Year
Expense Growth
+19.0%
Year-over-Year
Assets Growth
+20.6%
Year-over-Year
Equity Growth
+13.1%
Year-over-Year
Liabilities Growth
+20.6%
Year-over-Year
Operating Cash Flow Growth
+218.6%
Year-over-Year
Investing Cash Flow Growth
-76.0%
Year-over-Year
Financing Cash Flow Growth
+306.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Jun 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 588 | 582 | 545 | 499 | 473 | 491 | 514 | 485 | 410 | 413 | 467 | 426 | 442 | 436 | 390 | 387 | 220 | 234 | 434 | 176 | 162 | 112 | 211 | 151 | 129 | 163 |
| Expenses | 514 | 510 | 476 | 432 | 409 | 425 | 448 | 420 | 352 | 353 | 400 | 369 | 387 | 377 | 335 | 339 | 182 | 194 | 381 | 142 | 136 | 86 | 176 | 122 | 106 | 133 |
| EBITDA | 74 | 71 | 70 | 67 | 64 | 66 | 66 | 65 | 58 | 60 | 67 | 58 | 56 | 59 | 55 | 48 | 38 | 40 | 53 | 34 | 26 | 26 | 35 | 29 | 23 | 30 |
| Operating Profit Margin % | 12.00% | 12.00% | 12.00% | 13.00% | 13.00% | 13.00% | 13.00% | 13.00% | 13.00% | 14.00% | 14.00% | 13.00% | 12.00% | 13.00% | 14.00% | 12.00% | 17.00% | 16.00% | 11.00% | 18.00% | 15.00% | 22.00% | 16.00% | 19.00% | 17.00% | 18.00% |
| Depreciation | 18 | 18 | 18 | 15 | 16 | 15 | 18 | 15 | 16 | 14 | 15 | 16 | 17 | 15 | 16 | 10 | 7 | 6 | 16 | 6 | 5 | 4 | 6 | 4 | 4 | 4 |
| Interest | 6 | 6 | 6 | 4 | 3 | 4 | 5 | 5 | 4 | 6 | 4 | 8 | 5 | 5 | 5 | 2 | 1 | 1 | 5 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 50 | 48 | 46 | 48 | 46 | 47 | 42 | 45 | 37 | 40 | 48 | 34 | 34 | 39 | 35 | 36 | 30 | 33 | 33 | 28 | 20 | 21 | 28 | 24 | 19 | 25 |
| Tax | 13 | 13 | 13 | 13 | 11 | 12 | 11 | 12 | 8 | 10 | 13 | 10 | 10 | 10 | 9 | 10 | 8 | 9 | 10 | 7 | 5 | 5 | 7 | 6 | 5 | 6 |
| Net Profit | 37 | 34 | 34 | 35 | 34 | 35 | 32 | 33 | 29 | 29 | 34 | 24 | 24 | 29 | 26 | 26 | 22 | 25 | 23 | 21 | 15 | 16 | 22 | 18 | 14 | 18 |
| Earnings Per Share (₹) | 6.66 | 6.22 | 6.07 | 6.39 | 6.18 | 6.32 | 5.73 | 5.97 | 5.25 | 5.30 | 6.23 | 4.34 | 4.37 | 5.21 | 4.66 | 4.77 | 4.32 | 4.52 | 4.09 | 4.07 | 3.11 | 3.19 | 4.16 | 3.66 | 2.93 | 3.77 |
Related Pages for Rossari Biotech
Additional stock information and data for ROSSARI
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 1,896 | 1,572 | 1,368 | 1,257 | 561 | 472 | 250 |
| Current Assets | 1,042 | 844 | 720 | 609 | 355 | 326 | 160 |
| Fixed Assets | 598 | 578 | 585 | 607 | 181 | 94 | 74 |
| Capital Work in Progress | 140 | 47 | 16 | 1 | 0 | 22 | 3 |
| Investments | 84 | 63 | 51 | 36 | 0 | 18 | 0 |
| Other Assets | 1,074 | 885 | 715 | 612 | 380 | 338 | 173 |
| LIABILITIES | |||||||
| Total Liabilities | 1,896 | 1,572 | 1,368 | 1,257 | 561 | 472 | 250 |
| Current Liabilities | 174 | 100 | 104 | 157 | 2 | 36 | 4 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 1,185 | 1,048 | 915 | 805 | 409 | 287 | 124 |
| Share Capital | 11 | 11 | 11 | 11 | 10 | 10 | 4 |
| Reserves & Surplus | 1,174 | 1,037 | 904 | 794 | 398 | 277 | 119 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 137 | 43 | 152 | 29 | 48 | 57 | 71 |
| Investing Activities | -183 | -104 | -181 | -299 | -37 | -190 | -37 |
| Financing Activities | 65 | 16 | 61 | 292 | -25 | 157 | -29 |
| Net Cash Flow | 19 | -44 | 32 | 22 | -14 | 24 | 5 |